『Medlines』のカバーアート

Medlines

Medlines

著者： Human Content Inc.
無料で聴く

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり
Healthcare is changing at breakneck speed, and let's face it, staying informed is getting harder by the day. If only there were a way to get the industry news you need in less time than it takes to get prior auth approved. (Spoiler: There is.) Every Friday, start your day with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week's most important headlines across clinical care, health policy, groundbreaking publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals. Prepare to wow your colleagues with how informed you are, all without risking another evening doom-scrolling through 5% actual news and 95% videos of, well, if you know you know. Medicine moves fast... So do we! Learn More: www.medlinespod.com Medlines is A Human Content Production© 2026 Human Content, Inc. and Glaucomflecken, LLC. All rights reserved. 政治・政府 生物科学 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Schizophrenia Gets an App and Your Dog Is Losing Sleep

    Schizophrenia Gets an App and Your Dog Is Losing Sleep
    2026/10/16
    Friday, October 16, 2026 In today's episode, Dr. Alok Patel (@alokpatelmd) & Eva Johnson cover the FDA clearance of Motivista as the first prescription app for negative symptoms of schizophrenia. They break down the 16 week CONVOKE trial and what a 2.6 point edge over a control app means for stable patients on antipsychotics. They also review new ACP guidance placing menopausal hormone therapy first for hot flashes and night sweats, with second and third line options. Plus: they discuss early feasibility data on a medical AI chatbot for pre visit histories, new federal recommendations on concentrated kratom products, and more. Coverage Timeline: (00:00) Intro (01:08) Schizophrenia App Cleared (03:50) Hot Flashes Guidance (04:47) Dogs & Sleep Study (06:51) AI In Urgent Care (08:37) Awards & Dahlias Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production
    続きを読む 一部表示
    14 分
  • GLP-1 Shakeups and Airline Emergency Kit Upgrades

    GLP-1 Shakeups and Airline Emergency Kit Upgrades
    2026/10/09
    Friday, October 9, 2026 In today's episode, Dr. Will Flanary (@drglaucomflecken) & Adam Rose (@adjoro) cover Phase 3 results for retatrutide with up to 28.3% average weight loss at 80 weeks. They explain dosing, tolerability and what remains unproven for heart and kidney outcomes and how retatrutide compares with current GLP-1 options. They also break down a federal proposal to modernize airline emergency kits around nine life threatening categories with airline level discretion. Plus: they discuss a growing pediatric heart valve, the return of Doc, Best Medicine, Chicago Med and Grey’s Anatomy, and more. Coverage Timeline: (00:00) Intro (00:50) Retatrutide Weight Loss Trial (03:27) FAA Airline Medical Kits (06:56) Growing Heart Valve (07:26) Fasting Before Blood Work (08:18) Medical Drama Premieres Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit https://www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: https://www.medlinespod.com/sources Medlines is a Human Content Production
    続きを読む 一部表示
    12 分
  • The Future of Cancer Screening and... Horse Therapy?

    The Future of Cancer Screening and... Horse Therapy?
    2026/10/02
    Friday, October 2, 2026 In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) joins Medlines as a new anchor! She and Eva Johnson cover an FDA advisory panel vote on an early cancer detection blood test for adults 50 and older. The panel called the test safe, then split on whether it works. The agency still has to rule. They also walk through a UCSF comparison of myomectomy and radiofrequency ablation for uterine fibroids. Both treatments improved symptoms over two years, and neither difference reached the study threshold for a clinically important advantage. Plus: new findings on animal therapy, and more. Coverage Timeline: (00:00) Intro (02:01) FDA Backs Multi-Cancer Blood Test (05:08) Uterine Fibroids: Surgery vs. Heat Therapy (07:47) Gambling ER Visits Surge (09:01) Miniature Horses Lift Teen Mood Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production
    続きを読む 一部表示
    13 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません